Anterix (ATEX) Common Equity (2014 - 2026)

Anterix (ATEX) has reported Common Equity for 13 consecutive years, with $285.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 54.67% year-over-year to $285.8 million; the trailing twelve-month figure through Jun 2026 stood at $285.8 million (up 54.67% YoY), and the FY2026 full-year result was $262.3 million, up 67.51% from the prior year.
• Common Equity rose to $285.8 million in Q2 2026 per ATEX's latest filing, from $262.3 million in the prior quarter.
• Across five years, Common Equity topped out at $285.8 million in Q2 2026 and bottomed at $139.1 million in Q3 2024.
• Historically, Common Equity has averaged $186.4 million across 5 years, with a median of $175.3 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Common Equity declined 22.11% in 2022, then jumped 72.83% in 2025.
• Over 5 years, Common Equity stood at $159.0 million in 2022, then gained by 8.33% to $172.3 million in 2023, then decreased by 15.97% to $144.7 million in 2024, then surged by 63.01% to $236.0 million in 2025, then increased by 21.12% to $285.8 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $285.8 million, $262.3 million, and $236.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.